Search research articles
Contact Us
Filters
Showing results (101-110 of 182) with videos related to
Page
of 19
Sort By:
Journal of Gastroenterology and Hepatology
|
June 6, 2013
Association of MDM2 T309G and p53 Arg72Pro polymorphisms and gastroesophageal reflux disease with survival in esophageal adenocarcinoma
Daniel J Renouf, Rihong Zhai, Bin Sun, et al.
Pancreas
|
August 29, 2018
Characterization of the Neuroendocrine Tumor Immune Microenvironment
Annacarolina da Silva, Michaela Bowden, Sui Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2008
Activity of sunitinib in patients with advanced neuroendocrine tumors
Matthew H Kulke, Heinz-Josef Lenz, Neal J Meropol, et al.
The Journal of Clinical Investigation
|
May 21, 2026
Multiomic analyses delineate human neuroendocrine tumor cell states in relation to normal enteroendocrine cell ontogeny
Pratik Np Singh, Elsa Hadj Bachir, James R Howe, et al.
Endocrine-Related Cancer
|
July 12, 2014
Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide
Matthew H Kulke, Thomas O'Dorisio, Alexandria Phan, et al.
Carcinogenesis
|
May 11, 2010
A Large-scale genetic association study of esophageal adenocarcinoma risk
Chen-Yu Liu, Michael C Wu, Feng Chen, et al.
Journal of Gastrointestinal Cancer
|
March 9, 2020
Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Phase III Studies in Carcinoid Syndrome
Joseph S Dillon, Matthew H Kulke, Dieter Hörsch, et al.
Cancer Chemotherapy and Pharmacology
|
June 21, 2006
Phase I and pharmacokinetic study of S-1 administered for 14 days in a 21-day cycle in patients with advanced upper gastrointestinal cancer
Andrew X Zhu, Jeffrey W Clark, David P Ryan, et al.
The Journal of Molecular Diagnostics : JMD
|
August 11, 2007
DNA degradation test predicts success in whole-genome amplification from diverse clinical samples
Fengfei Wang, Lilin Wang, Christine Briggs, et al.
Pancreas
|
July 29, 2010
NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas
Matthew H Kulke, Lowell B Anthony, David L Bushnell, et al.
Page
of 19
Search research articles
Search
Showing results (101-110 of 182) with videos related to
Sort By:
Page
of 19
Journal of Gastroenterology and Hepatology
|
June 6, 2013
Association of MDM2 T309G and p53 Arg72Pro polymorphisms and gastroesophageal reflux disease with survival in esophageal adenocarcinoma
Daniel J Renouf, Rihong Zhai, Bin Sun, et al.
Pancreas
|
August 29, 2018
Characterization of the Neuroendocrine Tumor Immune Microenvironment
Annacarolina da Silva, Michaela Bowden, Sui Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2008
Activity of sunitinib in patients with advanced neuroendocrine tumors
Matthew H Kulke, Heinz-Josef Lenz, Neal J Meropol, et al.
The Journal of Clinical Investigation
|
May 21, 2026
Multiomic analyses delineate human neuroendocrine tumor cell states in relation to normal enteroendocrine cell ontogeny
Pratik Np Singh, Elsa Hadj Bachir, James R Howe, et al.
Endocrine-Related Cancer
|
July 12, 2014
Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide
Matthew H Kulke, Thomas O'Dorisio, Alexandria Phan, et al.
Carcinogenesis
|
May 11, 2010
A Large-scale genetic association study of esophageal adenocarcinoma risk
Chen-Yu Liu, Michael C Wu, Feng Chen, et al.
Journal of Gastrointestinal Cancer
|
March 9, 2020
Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Phase III Studies in Carcinoid Syndrome
Joseph S Dillon, Matthew H Kulke, Dieter Hörsch, et al.
Cancer Chemotherapy and Pharmacology
|
June 21, 2006
Phase I and pharmacokinetic study of S-1 administered for 14 days in a 21-day cycle in patients with advanced upper gastrointestinal cancer
Andrew X Zhu, Jeffrey W Clark, David P Ryan, et al.
The Journal of Molecular Diagnostics : JMD
|
August 11, 2007
DNA degradation test predicts success in whole-genome amplification from diverse clinical samples
Fengfei Wang, Lilin Wang, Christine Briggs, et al.
Pancreas
|
July 29, 2010
NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas
Matthew H Kulke, Lowell B Anthony, David L Bushnell, et al.
Page
of 19